Gottlieb says COVID-19 vaccine for kids could be approved by early winter
Pfizer's two-dose vaccine is already authorized for emergency use in children ages 12 to 15.
Watch CBS News
Pfizer's two-dose vaccine is already authorized for emergency use in children ages 12 to 15.
Hurricane Ida made landfall in Louisiana as a Category 4 storm Sunday afternoon. Many hospitals in the area were unable to evacuate, and are instead riding out what's being called an "extremely dangerous" storm. Louisiana Senator Bill Cassidy joins CBSN's Lana Zak to discuss what the state is doing to prevent the spread of COVID-19 at evacuation shelters.
Ivermectin has been approved by the Food and Drug Administration only to treat river blindness, intestinal strongyloidiasis, head lice and rosacea in humans.
The U.S. is in the grip of a fourth wave of infection this summer, powered by the highly contagious Delta variant, which has sent cases, hospitalizations and deaths soaring again.
"I don't want to sit an office for eight hours a day with someone who is not vaccinated," one employee said.
The U.S. is averaging more than 142,000 new coronavirus cases per day. Janet Shamlian reports from Oregon where hospitals are filling up. Then, Dr. Hilary Fairbrother, an emergency medicine physician, joins CBSN's Lana Zak to discuss the day's coronavirus headlines.
Leaders tell anxious residents the already-lagging vaccination program won't be disrupted, as COVID's resurgence causes heartache and Paralympic angst.
The average hospital stay for employees with COVID-19 costs the airline $50,000 per person, CEO Ed Bastian said.
Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up. The vaccine still remains under emergency use authorization for children 12 to 15. Dr. Jessica Shepherd, chief medical officer at Verywell Health, joins CBSN AM with a look at what this means for adults, children and people who've hesitated to get the vaccine.
Johnson & Johnson released data on its booster shot that shows a second dose eight months after the initial dose increases immunity. CBS News' Mark Strassmann has more on the company's announcement amid a surge in pediatric COVID cases. Then, Dr. Jeremy Faust, an attending physician at Brigham and Women's Hospital's department of emergency medicine, joins CBSN's Lana Zak to discuss the rest of the day's coronavirus headlines.
Johnson & Johnson said a booster shot of its COVID vaccine generates a "rapid and robust" spike in antibodies. Mark Strassmann shares more.
Johnson & Johnson says new research shows a second shot of its COVID vaccine boosts antibodies nine-fold. Meanwhile, the debate over mask and vaccine mandates is dividing Americans. CBS News national correspondent Mark Strassmann reports, then Dr. Amesh Adalja from Johns Hopkins University Bloomberg School of Public Health joins CBSN to discuss the latest research.
A second shot of its coronavirus vaccine offered ninefold increase in antibodies, drugmaker says.
Health officials are urging Americans to get vaccinated as most U.S. counties experience "high" coronavirus transmission. As CBS News' Manuel Bojorquez reports, Dr. Fauci says the nation could get control of the virus by next spring if more people roll up their sleeves. Then, Dr. Adam Brown, an emergency physician and the COVID national task force chair at Envision Healthcare, joins CBSN's Elaine Quijano to discuss the rest of the day's COVID headlines.
State lists "No mandated COVID-19 vaccination" as one of the "many great benefits" of its nursing jobs.
Expect "a very quick domino effect of employers taking advantage of this," one labor attorney said.
The White House coronavirus response coordinator is urging businesses to implement vaccine requirements after the FDA gave full approval to Pfizer's COVID vaccine. This comes as tens of millions of Americans who are eligible to get a COVID shot haven't. Manuel Bojorquez reports.
The Food and Drug Administration announced that it has granted full approval to Pfizer and BioNTech for their COVID-19 vaccine.
Pfizer's coronavirus vaccine has received full FDA approval, just eight months after it was authorized for emergency use. David Begnaud reports on efforts to boost lagging vaccinations. Then, Dr. Andre Campbell, a critical care physician and a professor at the University of California at San Francisco, joins CBSN's Elaine Quijano to discuss the latest.
Now that FDA has fully authorized the Pfizer vaccine, many businesses are expected to make vaccination mandatory.
The move comes following the FDA giving full approval to the Pfizer COVID-19 vaccine
The nation's largest public school district will require COVID-19 vaccines for teachers and staff, and testing won't be an acceptable alternative.
President Biden spoke about the nationwide vaccination effort after the FDA granted full approval to the Pfizer-BioNTech COVID-19 vaccine, clearing the way for the U.S. military and a growing number of companies and schools to require the shots. Jeff Pegues anchors this CBS News Special Report with senior White House and political correspondent Ed O'Keefe and medical contributor Dr. David Agus.
Health officials hope the move could help reverse the nationwide slowdown in vaccinations.
Congressman Ro Khanna is part of a bipartisan group of lawmakers calling on the FDA to release an update on when COVID-19 vaccines may be available for children under 12. Khanna, a Democrat from California, joined CBSN to talk about what they want to know as kids head back to school amid the ongoing pandemic.